Search Medical Condition
Please enter condition
Please choose location
 

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (908) clinical trials

This study is a Phase 2, randomized, placebo controlled, dose ranging study of piromelatine (5, 20, and 50 mg daily for 6 months) versus placebo to determine an effective dose based on efficacy (cognitive performance), safety and tolerability in patients with mild dementia due to AD.

Phase

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type.

Phase

The purpose of the study is to determine whether lowering systolic blood pressure and cholesterol, alone or in combination with aerobic exercise, can improve memory function of the brain in older adults at higher risk for developing dementia. This study will last 2 years. There are outpatient visits (2-5 hours ...

Phase N/A

A research study is evaluating an investigational medication for mild Alzheimer’s Disease dementia. This research study may be an option for your loved one if: They are 55-85 years of age They have a diagnosis of mild Alzheimer’s Disease dementia All their medication is stable for at least 30 days ...

Phase N/A

We are recruiting for the following populations: Age 50 to 80 Experiencing a decline in memory Or already diagnosed with Alzheimer’s disease (mild to moderate stage) The study involves one screening visit. If you qualify for the research study, the procedures will be done on the same day. If you ...

Phase N/A

The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive decline compared with placebo treatment, as measured by a composite cognitive measure, the Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia.

Phase N/A

The main purpose of this study is to evaluate the efficacy of the study drug known as LY3314814 in participants with mild Alzheimer's disease (AD) dementia.

Phase